ZSP-1241

N/A

Report date: 2022/06/07 10:26:40
NME

Base Information

Drug NameZSP-1241
Drug Alias NameZSP-1241
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionFibroblast growth factor receptor 4 antagonists
TargetsFibroblast growth factor receptor 4
Therapy Area/IndicationsLiver NeoplasmsStomach NeoplasmsColorectal Neoplasms +[8] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesGuangdong Zhongsheng Pharmaceutical Co LtdWuxi Apptec Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesGuangdong Zhongsheng Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsLiver NeoplasmsStomach NeoplasmsColorectal Neoplasms +[6] 
Inactive IndicationsCholangiocarcinomaCarcinoma, Hepatocellular

Other Information

ATC CodeN/A
Related LinksN/A